202 related articles for article (PubMed ID: 34273249)
21. Acral lentiginous melanoma. A clinicopathologic study of 36 patients.
Paladugu RR; Winberg CD; Yonemoto RH
Cancer; 1983 Jul; 52(1):161-8. PubMed ID: 6850538
[TBL] [Abstract][Full Text] [Related]
22. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients.
Teramoto Y; Keim U; Gesierich A; Schuler G; Fiedler E; Tüting T; Ulrich C; Wollina U; Hassel JC; Gutzmer R; Goerdt S; Zouboulis C; Leiter U; Eigentler TK; Garbe C
Br J Dermatol; 2018 Feb; 178(2):443-451. PubMed ID: 28707317
[TBL] [Abstract][Full Text] [Related]
23. Acral lentiginous melanoma with multiple bone metastasis: case report.
Chen PT; Manvar K; Chaudhry R; Wu R; Wang JC
Pan Afr Med J; 2023; 45():141. PubMed ID: 37808429
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and Management of Acral Lentiginous Melanoma.
Nakamura Y; Fujisawa Y
Curr Treat Options Oncol; 2018 Jun; 19(8):42. PubMed ID: 29951919
[TBL] [Abstract][Full Text] [Related]
25. Acral Lentiginous Melanoma: Survival Analysis of 715 Cases.
Lino-Silva LS; Zepeda-Najar C; Salcedo-Hernández RA; Martínez-Said H
J Cutan Med Surg; 2019; 23(1):38-43. PubMed ID: 30221995
[TBL] [Abstract][Full Text] [Related]
26. Acral Lentiginous Melanoma - misdiagnosis, referral delay and 5 years specific survival according to site.
Boriani F; O'Leary F; Tohill M; Orlando A
Eur Rev Med Pharmacol Sci; 2014; 18(14):1990-6. PubMed ID: 25027337
[TBL] [Abstract][Full Text] [Related]
27. Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis.
Häfliger EM; Ramelyte E; Mangana J; Kunz M; Kazakov DV; Dummer R; Cheng PF
Melanoma Res; 2018 Oct; 28(5):442-450. PubMed ID: 29847461
[TBL] [Abstract][Full Text] [Related]
28. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
[TBL] [Abstract][Full Text] [Related]
29. Expression of p16 protein in acral lentiginous melanoma.
Hsieh R; Firmiano A; Sotto MN
Int J Dermatol; 2009 Dec; 48(12):1303-7. PubMed ID: 20415670
[TBL] [Abstract][Full Text] [Related]
30. Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance.
Choi ME; Jung JM; Kim DH; Won CH; Chang SE; Lee MW; Lee WJ
J Am Acad Dermatol; 2024 May; 90(5):977-985. PubMed ID: 38272394
[TBL] [Abstract][Full Text] [Related]
31. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Ramani NS; Aung PP; Gu J; Sfamenos S; Sdringola-Maranga C; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Diab A; Prieto VG; Hwu WJ; Torres-Cabala CA
Mod Pathol; 2020 Oct; 33(10):2067-2074. PubMed ID: 32404956
[TBL] [Abstract][Full Text] [Related]
32. Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia.
Duarte CA; Flórez JP; López HG; Meneses MX; de Vries E
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):438-442. PubMed ID: 27518480
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute.
Otsuka M; Yamasaki O; Kaji T; Iwatsuki K; Asagoe K
J Dermatol; 2015 Oct; 42(10):954-61. PubMed ID: 26074328
[TBL] [Abstract][Full Text] [Related]
34. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
[TBL] [Abstract][Full Text] [Related]
35. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
36. Acral lentiginous melanoma. A clinicopathologic entity.
Krementz ET; Feed RJ; Coleman WP; Sutherland CM; Carter RD; Campbell M
Ann Surg; 1982 May; 195(5):632-45. PubMed ID: 7073361
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
38. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
Lino-Silva LS; Domínguez-Rodríguez JA; Aguilar-Romero JM; Martínez-Said H; Salcedo-Hernández RA; García-Pérez L; Herrera-Gómez Á; Cuellar-Hubbe M
Ann Surg Oncol; 2016 Dec; 23(13):4189-4194. PubMed ID: 27401447
[TBL] [Abstract][Full Text] [Related]
39. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
[TBL] [Abstract][Full Text] [Related]
40. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
Søndergaard K
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
